Similarly, praeruptorin B (20, 40, 60 μmol/L) was reported to inhibit both the proliferation and migration of SK-OV-3 ovarian cancer cells, as well as downregulate the expression of FASN, c-Myc, SREBP-1c, and cyclin D1. Here, SREBF1 is linked to ovarian carcinoma.